These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7197539)

  • 1. [Studies on the pharmacology and toxicology of ciclopiroxolamine (author's transl)].
    Alpermann HG; Schütz E
    Arzneimittelforschung; 1981; 31(8A):1328-32. PubMed ID: 7197539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microbiological laboratory studies with ciclopiroxolamine (author's transl)].
    Dittmar W; Grau W; Raether W; Schrinner E; Wagner WH
    Arzneimittelforschung; 1981; 31(8A):1317-22. PubMed ID: 7197538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical results with the antimycotic agent ciclopiroxolamine (author's transl)].
    Adam W; Peil HG; Savopoulos C; Vanderbeke O
    Arzneimittelforschung; 1981; 31(8A):1360-5. PubMed ID: 7028047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Liberation of ciclopiroxolamine from dermatological preparations (author's transl)].
    Petri W
    Arzneimittelforschung; 1981; 31(8A):1332-7. PubMed ID: 7197540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Open clinical trial in dermal mycoses of a 1% ciclopiroxolamine solution in polyethylene glycol 400 carried out in FR Germany/Study with shortened therapy (author's transl)].
    Torres J; Savopoulos C; Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1373-6. PubMed ID: 7028049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the local efficacy of ciclopiroxolamine in onychomycoses (author's transl)].
    Qadripur SA; Horn G; Höhler T
    Arzneimittelforschung; 1981; 31(8A):1369-72. PubMed ID: 6457608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Penetration and antifungal activity of ciclopiroxolamine in hornified tissue (author's transl)].
    Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1353-9. PubMed ID: 7197542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-European open clinical studies on the efficacy and tolerance of ciclopiroxolamine in dermatomycoses (author's transl)].
    Dittmar W
    Arzneimittelforschung; 1981; 31(8A):1381-5. PubMed ID: 7028052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the mechanism of antifungal action of ciclopiroxolamine/Inhibition of transmembrane transport of amino acid, K+ and phosphate in Candida albicans cells (author's transl)].
    Iwata K; Yamaguchi H
    Arzneimittelforschung; 1981; 31(8A):1323-7. PubMed ID: 7028046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration].
    Kellner HM; Arnold C; Christ OE; Eckert HG; Herok J; Hornke I; Rupp W
    Arzneimittelforschung; 1981; 31(8A):1337-53. PubMed ID: 7197541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative double-blind study on ciclopiroxolamine cream and placebo cream in dermatophytoses (author's transl)].
    Fredriksson T; Savopoulos C
    Arzneimittelforschung; 1981; 31(8A):1376-8. PubMed ID: 7028050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Open clinical study on the efficacy and tolerance of ciclopiroxolamine in vulvovaginal candidosis (author's transl)].
    Peil HG
    Arzneimittelforschung; 1981; 31(8A):1366-8. PubMed ID: 7028048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro antifungal spectrum of ciclopiroxolamine].
    Goudard M; Regli P; Lubrano N
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):621-3. PubMed ID: 2797886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General pharmacology of recombinant human basic fibroblast growth factor.
    Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
    Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selected double-blind comparative studies on the efficacy and tolerance of ciclopiroxolamine solution and cream].
    Beyer M
    Arzneimittelforschung; 1981; 31(8A):1378-81. PubMed ID: 7028051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy.
    Weir SJ; Patton L; Castle K; Rajewski L; Kasper J; Schimmer AD
    J Clin Pharm Ther; 2011 Apr; 36(2):128-34. PubMed ID: 21366640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 4. Toxicity and general pharmacology of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexy l-2-imino- imidazolidine (CGP 11 112).
    Märki F; Büch O; Delini-Stula A; Kraetz J; Petermann H; Radeke E; Schweizer A; Thomann P; Truog A
    Arzneimittelforschung; 1984; 34(3):247-52. PubMed ID: 6539603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [General pharmacology of T-2588, a new oral cephem antibiotic].
    Hirai S; Kodama T; Hiraiwa T; Abe N; Arai H; Ono S; Omori M; Nakada Y; Hashiba K; Tanada K
    Jpn J Antibiot; 1986 Apr; 39(4):958-78. PubMed ID: 3761550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [General pharmacology of aclacinomycin A (author's transl)].
    Ohmori K; Hirano S; Hori S
    Jpn J Antibiot; 1980 Feb; 33(2):192-213. PubMed ID: 6929361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.